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Abstract
Smoking during pregnancy is a persistent public health problem that has been linked to later adverse outcomes. The neonatal period—the first month of life—carries substantial developmental change in regulatory skills and is the period when tobacco metabolites are cleared physiologically. Studies to date mostly have used cross-sectional designs that limit characterizing potential impacts
of prenatal tobacco exposure on the development of key self-regulatory processes and cannot disentangle short-term withdrawal
effects from residual exposure-related impacts. In this study, pregnant participants (N = 304) were recruited prospectively during
pregnancy, and smoking was measured at multiple time points, with both self-report and biochemical measures. Neonatal attention,
irritable reactivity, and stress dysregulation were examined longitudinally at three time points during the first month of life, and
physical growth indices were measured at birth. Tobacco-exposed infants showed significantly poorer attention skills after birth,
and the magnitude of the difference between exposed and nonexposed groups attenuated across the neonatal period. In contrast, exposure-related differences in irritable reactivity largely were not evident across the 1st month of life, differing marginally at 4 weeks
of age only. Third-trimester smoking was associated with pervasive, deleterious, dose–response impacts on physical growth measured at birth, whereas nearly all smoking indicators throughout pregnancy predicted level and growth rates of early attention. The
observed neonatal pattern is consistent with the neurobiology of tobacco on the developing nervous system and fits with developmental vulnerabilities observed later in life.
Keywords: prenatal tobacco exposure, self-regulation, longitudinal modeling

Approximately 20% of women acknowledge smoking during pregnancy in the United States (National Survey on Drug
Use and Health; Office of Applied Studies, 2005), which results
in at least 500,000 prenatally tobacco-exposed infants annually. Smoking during pregnancy is substantially more prevalent than prenatal use of alcohol or illicit drugs. For most
women, smoking is a daily habit that, when pregnant, results
in a regular dosing pattern to the fetus. As such, prenatal tobacco exposure carries broad risk for harm and potential morbidity (Koren, 1993; Slotkin, 1998b).
Tobacco contains a number of chemically active compounds. Nicotine appears to be the predominant contributor to the impact on growth and behavior of children exposed
during pregnancy. Nicotine is a powerful vasoconstrictor that
reduces the flow of available nutrients and oxygen to the developing fetus. Indeed, exposure-related reductions in birth
weight have been reported in the literature for several decades. Besides birth weight, prenatal tobacco exposure is also
associated with dose-dependent reductions in body length
and head size (e.g., Hardy & Mellits, 1972; Rantakallio, 1983;

Roza et al., 2007; Vik, Jacobsen, Vatten, & Bakketeig, 1996).
These exposure-related physical growth differences at birth
usually resolve by the infant’s first birthday (Conter, Cortinovis, Rogari, & Riva, 1995; Day et al., 1992; Hardy & Mellits,
1972). The physical growth deficits and the associated tobaccoexposure–related increase in perinatal complications both contribute to, but do not completely account for, a greater risk for
attention-deficit/hyperactivity disorder (Nigg & Breslau, 2007;
Szatmari, Saigal, Rosenbaum, Campbell, & King, 1990; Willoughby, Greenberg, Blair, Stifter, & Family Life Investigative
Group, 2007).
Although largely ignored for decades, nicotine is also a
psychoactive compound that acts directly on the brain. Nicotine activates nicotinic acetylcholine receptors that are situated on dopamine neurons in the striatum and noradrenergic neurons in the locus coeruleus (Lichtensteiger et al., 1982)
and are present as early as eight weeks gestation (Hagino &
Lee, 1985). In elegant preclinical work in nonhuman animals,
prenatal tobacco exposure has been found to disrupt the timing of cholinergic synaptic activity during key developmen1

2
tal periods, to alter receptor-mediated processes controlling
cell replication and differentiation (Slotkin, 1998a), and to result in abnormal neuronal reactivity (Landmesser, 1994; Navarro, Seidler, Whitmore, & Slotkin, 1988; Seidler, Levin,
Lappi, & Slotkin, 1992; Slotkin, Lappi, & Seidler, 1995), including the disruption of developing dopaminergic circuits
(Azam, Chen, & Leslie, 2007). When administered prenatally,
nicotine reduces postnatal dopaminergic activity in the ventral tegmental area, nucleus accumbens, and striatum (Chen,
Parker, Matta, & Sharp, 2005; Muneoka et al., 1997; Slotkin,
1998b), with a corresponding reduction in D2 dopamine receptors (S. A. Richardson & Tizabi, 1994). Serotonergic systems are affected similarly, as prenatal tobacco exposure disrupts paroxetine binding to the 5-HT transporter (Levin &
Slotkin, 1998). These disruptions persist well after nicotine
exposure has ceased (McFarland, Seidler, & Slotkin, 1991),
suggesting that prenatal nicotine exposure alters cell development programs in an irreversible manner (Slotkin, 1998b)
that is not attributable solely to the hypoxic effects of nicotine on the central nervous system (Slotkin, Greer, Faust,
Cho, & Seidler, 1986).
Given the strong link between alterations of the dopaminergic and serotonergic brain systems and developmental
psychopathology, it may not be surprising that many studies
have linked prenatal tobacco exposure to externalizing behaviors in childhood (e.g., Day, Richardson, Goldschmidt, & Cornelius, 2000; Wakschlag, Leventhal, Pine, Pickett, & Carter,
2006) and to the clinical diagnoses of attention-deficit/hyperactivity disorder and oppositional defiant disorder (Huizink
& Mulder, 2006; Kotimaa et al., 2003; Orlebeke, Knol, & Verhulst, 1999; Wakschlag, Pickett, Cook, Benowitz, & Leventhal, 2002). Furthermore, self-reported prenatal smoking also
has been associated with inattention, overactivity, and an impulsive response style at preschool and early school age (Day
et al. 2000; Fried, Watkinson, & Gray, 1992; Johnson, Vicary,
Heist, & Corneal, 2001; Leech, Richardson, Goldschmidt, &
Day, 1999), working memory and inhibition deficits in adolescents (Bennett et al., 2009; Fried & Watkinson, 2001; Jacobsen, Slotkin, Westerveld, Mencl, & Pugh, 2006), and negative
emotionality in infants and young children (Brook, Brook,
& Whiteman, 2000; Fried & Makin, 1987; Kelmanson, Erman, & Litvina, 2002; Schuetze & Eiden, 2007; Wakschlag &
Hans, 2002; Willoughby, Greenberg, Blair, Stifter, & Family
Life Investigative Group, 2007). Dose–response relations between prenatal tobacco exposure and such externalizing behaviors have been reported (e.g., Day et al., 2000; Linnet et
al., 2003; Williams et al., 1998). Generally, the effect of exposure on these outcomes is robust but may be reduced in magnitude when adjusted for confounding environmental and genetic covariates (Linnet et al., 2003; Maughan, Taylor, Caspi,
& Moffitt, 2004; Rodriguez & Bohlin, 2005; Thapar et al., 2003)
or is eliminated in epidemiological within-family, sibling designs (e.g., D’Onofrio et al., 2007).
Results of studies conducted on newborns in the 1970s and
1980s with self-reported measures of smoking suggest exposure-related vulnerabilities in self-regulation. Saxton (1978) examined infant behavior shortly after birth in a small sample
of infants born to women who smoked 15 or more cigarettes
per day. Tobacco-exposed neonates showed reduced sensitivity to auditory stimuli, evidenced by greater auditory habituation and poorer orientation to auditory inanimate and animate stimuli. Other researchers (Fried, Watkinson, Dillon, &
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Dulberg, 1987; Picone, Allen, Olsen, & Ferris, 1982) confirmed
these findings and noted reductions in visual attention skills
(S. W. Jacobson, 1984; G. A. Richardson, Day, & Taylor, 1989;
Streissguth, Sampson, Barr, Bookstein, & Carmichael, 1994).
Alterations in state behavior (i.e., increased irritability; Fried
& Makin, 1987; S. W. Jacobson, 1984; Stroud, Paster, Goodwin,
et al., 2009), disrupted cry (Nugent, Lester, Greene, & Wieczorek-Deering, 1996), and autonomic regulation (Picone et al.,
1982) also have been associated with prenatal tobacco exposure, although not in all studies (G. A. Richardson et al., 1989).
More recently, a handful of studies that included bioassay validation of exposure confirmed differences in withdrawal behaviors (heightened irritability, physiologic signs of stress) in
the first few days of life (Godding et al., 2004; Law et al., 2003;
Mansi et al., 2007) and hint at persistent differences later in the
neonatal period in reactivity to handling (Stroud, Paster, Papandonatos, et al., 2009).
Despite its relative temporal brevity, there is substantial
skill development in the neonatal period. Shortly after birth,
the newborn works to independently achieve physiological stability and homeostasis, including regulation of arousal
(Kopp, 1982; Riese, 1987). After homeostasis is achieved, the
neonate regulates responsiveness to external stimuli through
state modulation and directed orientation of attention (Bard,
Coles, Platzman, & Lynch, 2000; Emde & Buchsbaum, 1989).
Investigations that have focused on behavior shortly after
birth likely do not fully capture the impacts of prenatal exposure on skill development across the period. From the perspective of exposure, the neonatal period begins with physiological clearing of nicotine and other tobacco compounds from
maternal smoking late in pregnancy, where both exposure
and withdrawal effects are evident shortly after birth. Later in
the neonatal period, the persistent, residual impacts of exposure on neurobehavior can be observed without the confounding of short-term withdrawal behaviors. Furthermore, because
behavioral manifestations of brain alterations may not be evident until the age at which the compromised area is called into
action for skill execution (Goldman, 1974), in some cases long
after the damage occurred, new insights can be gained by examining exposure-related outcome with repeated measurements. For the neonatal period, longitudinal designs permit
characterization of how prenatal tobacco alters the developmental trajectory of regulatory skills and can help to disentangle short-term withdrawal from the more persistent, residual
effects of exposure.
Indeed, results from a handful of studies hint at persistent differences later in the neonatal period. Fried and Makin (1987), for example, found greater impairment in tobaccoexposed infants in motor response at 30 days of age than at 9
days of age. More recently, Stroud, Paster, Papandonatos, et
al. (2009) examined the impact of prenatal tobacco exposure
on the regulatory behavior of 56 neonates at 10 to 27 days. Exposed neonates did not differ from their socioeconomic status
(SES)- and alcohol exposure–matched peers in stress responses
or muscle tone, but exposed infants exhibited a greater need
for handling and scored lower on self-regulation items. In a
large sample of White and Black infants, the amount of exposure indexed by maternal serum cotinine was related to differences in arousal and regulation at 5 weeks of age (Yolton
et al., 2009). To date, no studies have leveraged longitudinal data to examine exposure-related differences across early
development.

Prenatal Tobacco Exposure: Developmental Outcomes
The purpose of the present study, then, was to delineate
the impact of prenatal tobacco exposure on the early development of emergent regulatory processes across the first month
of life—the neonatal period—using a prospective, cohort design with self-reported and bioassay indices of exposure collected repeatedly during pregnancy. Using hierarchical growth
modeling, we could then parse the effect of prenatal tobacco
exposure into effects that influence the level of self-regulatory
behavior at any given age and those that influence the rate of
behavior change or development to better characterize the impact of exposure on the underlying developmental process.
This modeling approach previously has been demonstrated
to be useful. For example, Espy, Riese, and Francis (1997) observed that prenatal cocaine exposure differentially affected
the developmental level and rate parameters. Building on extant findings, we hypothesized that tobacco-exposed neonates
would show reduced self-regulatory skills after birth, manifested by poorer attention and orientation, increased irritability and greater stress dysregulation, as well as persistent exposure-related differences at 4 weeks of age. Because our study
was motivated by a neural systems perspective to better characterize specific tobacco exposure effects, we were particularly
interested in isolating the impact of tobacco exposure as much
as possible and thus used strict participant selection procedures to minimize other exposures and influences. With these
selection methods, we postulated that differences in self-regulatory behaviors would be related in a dose–response manner to the number of cigarettes smoked by the mother during pregnancy, indexed by self-report and bioassays at each
trimester. We also examined exposure-related differences in
physical growth at birth, as these indices have been shown to
be important mediators in other behavioral teratologic studies
(e.g., head circumference and prenatal cocaine exposure; Eyler,
Behnke, Conlon, Woods, & Wobie, 1998). Finally, exposure-related differences in the development of rudimentary self-regulatory processes were explored by evaluating differences in the
rate of skill growth across the entire neonatal period.

Method
Participants
The sampling strategy was designed to compare two neonatal groups—tobacco exposed and nonexposed groups—and
to minimize the influences of other exposures and sociodemographic differences. Consistent with this objective, study flyers
were distributed over a 4.5-year period to all obstetric clinics
in two sites in the Midwest: rural multicounty area in southern Illinois (surrounding the town of Carbondale) and a smallsized city (Lincoln, Nebraska). Interested pregnant women (N =
915) called the laboratory and were screened for study eligibility with questions regarding due date, educational attainment,
maternal race, smoking history and status, alcohol and illegal
drug use, and (as a less intrusive proxy for income) Medicaid
status. Women who reported at screening (a) illegal drug use
or (b) alcohol use of four or more drinks on a single occasion
(criterion for binge drinking; Centers for Disease Control, 2008)
were eliminated as ineligible at screening and were not considered further for potential recruitment. Among screened women
who reported no binge drinking and no illegal drug use, all
women who reported smoking in the month around their last
menstrual period or current active smoking on the screening
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were then recruited, enrolled, and preliminarily classified as tobacco exposed. Smoking at last menstrual period was chosen
as the criterion to capture women who underdisclose smoking
during very early pregnancy, when in fact, they quit smoking
upon learning they were pregnant (which is well into the pregnancy period) and would therefore have been classified erroneously as nonexposed (England et al., 2007). Among screened
women who reported no binge drinking, no illegal drug use,
and no smoking at screening, those with lower educational attainment (<14 years), majority race/ethnicity, and Medicaid status were overselected for subsequent recruitment to render the
groups more comparable demographically given the known
higher frequency of smoking in these groups (N = 387 before
data exclusions described below). Most participants (65%) were
enrolled prior to the 16th prenatal week, and all women were
enrolled prior to the 28th prenatal week. Women’s self-reported
prenatal smoking behavior then was obtained prospectively at
16 weeks, 28 weeks, and delivery (hereinafter referred to as 40
weeks), with a modified timeline follow-back method (Sobell &
Sobell, 1992), where dates were used to cue recall and smoking
was queried month by month.
Next, self-reported smoking behavior was examined for
consistency with the initial group assignment. Where smoking
status was consistent across the interviews and agreed with
the last smoking date (if applicable), the exposure group assignment remained. For those who did not meet either of these
criteria, the reported last smoking dates across the interviews
were examined with regard to proximity of last menstrual period. If a participant was classified initially as nonexposed
but reported last smoking dates falling within the window of
pregnancy, then that participant was reclassified as tobacco
exposed. Ten smokers reported no cigarette use during pregnancy that was inconsistent with their last menstrual period
and reported last smoking dates. For these women, the missing average smoking amounts for the applicable trimesters
were imputed with regression modeling (Little & Rubin, 2002).
The results of the biospecimen sampling were then examined
to confirm smoking group assignment. We created plots of the
cotinine levels, the nicotine by-product that was assayed by
U.S. Drug Laboratories from samples collected from maternal
urine at 16, 28, and 40 weeks of the pregnancy and from infant meconium shortly after birth (see Procedures for further
details). Any nonsmoking woman with at least one urine cotinine value of 30 ng/ml or greater or whose infant had a meconium cotinine level of at least 30 ng/g was scrutinized further.
Two mothers were reclassified as tobacco exposed who had at
least one urine or infant meconium cotinine level greater than
100, the cutoff value recommended by U.S. Drug Laboratories.
Because the purpose of this article was to examine the impact of prenatal tobacco exposure while minimizing confounding influences and other exposures, data from women/
neonates who met one of the four following criteria were excluded from analysis. First, although women who reported
illegal drug use during screening were not recruited or enrolled, 53 women denied use at screening and then subsequently reported use of marijuana at a prenatal interview
(n = 38) or their infant’s meconium tested positive for marijuana at birth (n = 19). Second, one woman reported prescription antipsychotic medication use during pregnancy, which
has known negative impacts on neonatal behavior. Because
women who smoke are also more likely to drink, and to drink
more in one sitting, than nonsmokers, we carefully measured
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alcohol use around the last menstrual period and during each
month of pregnancy with the same structured, timeline follow-back methods as for smoking, querying about quantity,
frequency, and variability. In the present sample, 83% of the
women in the tobacco-exposed group reported drinking before pregnancy and prior to their last menstrual period compared with 61% percent of women in the nonexposed group,
χ2(1, N = 304)_18.51, p < .0001. Furthermore, the average number of alcoholic drinks consumed per day during the first trimester of pregnancy differed between tobacco-exposed and
nonexposed groups (shown in Table 1), as well as comparison
of groups among drinkers only: for tobacco-exposed drinkers
only, M = 0.18; SD = 0.23; for nonexposed drinkers only, M =
0.04, SD = 0.06; t(150) = –4.80, p < .0001. The data also were
excluded for eight women who reported at the first interview
drinking one or more drinks per day on average (criteria for
heavy drinking; Centers for Disease Control, 2008) for the first
trimester. Only those with heavy drinking in the first trimester were excluded because, after removing the data from these
eight women, we found that 85% of participants reported no
alcohol use after the end of the first trimester. Furthermore,
the amount and frequency of alcohol use in those who reported use after the first trimester was no more than one drink
on one specifically identified occasion (e.g., a holiday or birthday) for all but six women (Trimester 2, M = 0.028, SD = 0.028;
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Trimester 3, M = 0.076, SD = 0.082). Mean number of alcoholic
drinks consumed per day reported for both the second and
third trimesters for each exposure group (in Table 1) was very
low, as well as when comparing groups among drinkers only
(tobacco-exposed drinkers only: Trimester 2, M = 0.004, SD =
0.009; Trimester 3, M = 0.002, SD = 0.009; nonexposed drinkers only: Trimester 2, M = 0.007, SD = 0.026; Trimester 3, M
= 0.002, SD = 0.010). Although our focus was on prenatal tobacco exposure while minimizing other exposures, we elected
not to exclude the data from women who consumed any alcohol (even though in relatively low amounts in this sample)
to conserve sample size and preserve generalizability because
of the common comorbidity of smoking and alcohol use, particularly prior to pregnancy detection. Therefore, we included
prenatal alcohol use during the first trimester as a potential
covariate (see Procedures section below for further details). Finally, to minimize the well-known influence of gestational age
on self-regulatory behavior (Korner, Brown, Dimiceli, & Forrest, 1989; Riese, Wilson, & Matheny, 1985), data from 10 infants born preterm (before 36 weeks) also were removed. Of
the 10 removed, eight were tobacco exposed.
A total of 304 women and their infants met the criteria for
inclusion, with 143 infants classified as tobacco exposed and
161 as nonexposed (138 women/infants from the rural Illinois
site and 166 women/infants from the urban Nebraska site,

Table 1. Maternal Variables by Tobacco Exposure Group
t test
Maternal demographic, health, and perinatal variables

t

Tobacco exposed
(df)

M

SD

Nonexposed
%

M

SD

Maternal age at delivery (years)
2.08*
(302)
25.3
5.0 		
26.5
5.0
Maternal education (years)
4.51*** (302)
13.01
1.61
13.89
1.75
Median monthly family income ($)			
1,742 			
1,820
Gravida
–1.29
(302)
1.77
2.21 		
1.50
1.41
Parity
0.33
(302)
1.04
1.33		
1.09
1.05
Weight gain (first prenatal visit to delivery)
–1.74
(301)
27.7
15.5
24.7
14.5
Anemia 					
14 			
Medicaid 					
84 			
Married ** 					
36 			
Placental abruption 					
0.3 			
Delivery
Spontaneous vaginal 					
41 			
Induced vaginal 					
27 			
Caesarean and other extraction 					
32 			
Asthma medication 					
4 			
Pain medication 					
22 			
Antidepressant medication 					
12 			
Diabetes					
6 			
Hypertension/pre-eclampsia 					
11 			
Infection 					
11			
Heart disease 					
4 			
Thyroid disease 					
1 			
WJ-III BIA overall IQ estimate
2.88**
(297)
95.52
10.77		
99.23
12.29
BSI General Severity Index T score
–1.77
(300)
57.04
8.39		
55.34
8.39
CAARS Attention Deficit/Hyperactivity Disorder T score –0.87
(300)
46.74
8.26 		
45.96
7.87
Maternal prenatal drinking (drinks/day)
Trimester 1 average
–6.77*** (300)
0.127
0.206		
0.015
0.038
Trimester 2 average
–2.15*
(301)
0.003
0.008 		
0.001
0.006
Trimester 3 average
–2.30*
(302)
0.004
0.022 		
0.001
0.006

%

16
83
54
0.0
54
28
18
6
17
9
7
14
11
3
4

WJ-III BIA = Woodcock–Johnson III Brief Intellectual Ability Assessment (Woodcock, Johnson, & Mathers, 2001); BSI = Brief Symptom Inventory
(Derogatis, 1975); CAARS = Conners Adult ADHD Rating Scale, Short (Conners, Erhardt, & Sparrow, 1998).
* p < .05 ; ** p < .01 ; *** p < .001.

Prenatal Tobacco Exposure: Developmental Outcomes
where exposure groups by site were comparable).1 The sample
included 235 White, non-Hispanic women (77.3%); 15 White,
Hispanic women (4.9%); 40 African American women (13.2%);
and 9 Native American women (3.0%). On average, mothers
completed 13.5 years of education (SD = 1.7). Although language spoken in the home was not collected, all women were
proficient English speakers. Women in the tobacco-exposed
and nonexposed groups were comparable in the percentage
receiving Medicaid assistance but differed in the proportion
married at enrollment, age at delivery, and educational attainment. There were no differences between exposure groups
in the proportion of female infants, infant gestational age at
birth, or infants who were of White, non-Hispanic race/ethnicity. Tables 1 and 3 depict the respective descriptive statistics for women and neonate participants by exposure group.

Procedures
Tobacco exposure. Women were interviewed with the
structured, timeline follow-back method in a private room by
trained researchers (the research technicians who conducted
interviews were not the same as those who conducted neonatal evaluations to ensure blind assessment) at 16, 28, and 40
weeks (just after delivery) to gain information on prenatal tobacco and alcohol use. The comprehensive interview included
background and other health-related questions, as well as queries about quantity, frequency, and variability information regarding tobacco and alcohol use by month. These month-bymonth values were averaged into trimester indices. At each
session, women provided a urine sample in a sterile cup,
where 100% of women provided samples at the 16-week interview, 99% at 28 weeks, and 96% at delivery, as occasionally
women had difficulty providing a sufficiently clean sample
for cotinine assay after delivery. After the neonate was born,
nurses collected meconium samples until a total weight of 25
g was obtained. However, some neonates voided meconium in
utero or during delivery, preventing collection of an adequate
volume of meconium for later assay. A total of 255 neonate
meconium cotinine results were available for analysis.
Once nicotine is absorbed by the mother during smoking,
it is metabolized into cotinine and is detectable in the urine up
to several days after the termination of smoking. To measure
cotinine level in participants’ urine samples, we used the DRI
Cotinine Assay from U.S. Drug Laboratories. The DRI cotinine
assay is a liquid, ready-to-use homogeneous enzyme immunoassay based on competition between cotinine labeled with
glucose-6-phosphate dehydrogenase enzyme and free cotinine in the sample for a fixed amount of cotinine-specific antibody binding sites. The glucose- 6-phosphate dehydrogenase
enzyme activity is determined spectrophotometrically at 340
nm by measuring its ability to convert nicotinamide adenine
dinucleotide (NAD) to NAD-hydrogenase. This assay utilizes
DRI cotinine calibrators and controls, which are prepared by
spiking negative human urine with a known quantity of cotinine. The cotinine concentration is obtained by running a standard curve with the appropriate calibrators and by quantitat-
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ing samples off the standard curve.
The tobacco exposure information is provided in Table 2.
A total of 43% of the tobacco-exposed group reported smoking 10 or more cigarettes per day on average before pregnancy
and prior to the last menstrual period. The average number
of cigarettes smoked during each trimester and at the 16-, 28-,
and 40-week interviews was substantially less, between three
and six cigarettes per day. Although 39% of the women reported that they no longer smoked by the end of the first trimester and 50% reported no longer smoking by the end of the
second trimester, the average maternal urinary cotinine values for the tobacco-exposed group at 28 weeks did not differ
from those collected at 16 weeks: 16 weeks, M = 331 ng/mL,
SD = 537; 28 weeks, M = 353 ng/mL, SD = 564, t(87) = –0.72,
p > .45. The lowest average cotinine value for the tobacco-exposed group was at delivery. The average cotinine values for
the nonexposed group were less than 15 ng/ml across all occasions. As expected, the mean cotinine values in maternal urine
and neonate meconium differed between the tobacco-exposed
and nonexposed groups at all time points (all ps < .01). Table 4
provides intercorrelations of the self-reported smoking behavior variables and the cotinine assay results at all time points.
Neonate urine samples were collected from soft cloths inserted into the diaper at the 2- and 4-week sessions to assess
environmental tobacco smoke exposure. U.S. Drug Laboratories conducted the DRI cotinine assay on these postnatal urine
samples. Tobacco-exposed and nonexposed group mean 2and 4-week neonate urinary cotinine levels did not differ and
are shown in Table 2.
Neonatal assessment. Although the state ratings, auditory
and visual stimuli, and reflex maneuvers are similar among
most neonatal instruments as a result of the limited behavioral repertoire of the young neonate, we chose the Neonatal
Temperament Assessment (NTA) to measure emergent regulatory skills because of its unique modules that include graded
stressors designed to probe the regulatory system and known
psychometric properties. Psychometric properties of the NTA
have been reported as good (Riese, 1982), where interrater reliability and internal consistency range from 0.85 to 0.97 and
0.72 to 0.86, respectively (Riese, 1983). We calculated interrater reliabilities from coscoring 4% of all assessments administered, with obtained reliabilities ranging from .89 to .99. With
regard to predictive validity, Riese and colleagues (Matheny,
Riese, & Wilson, 1985; Riese, 1995; Riese, Wilson, & Matheny,
1985) have shown that neonatal temperament is related to
later maternal reports and direct laboratory behavioral observations of infant temperament at 6 months, 9 months, and 2
years. In these studies, those who were more irritable perinatally were rated as more upset, more variably active, less attentive to stimuli, and less responsive (Riese, 1987).
Research technicians administered the standardized NTA,
which was designed to evaluate individual differences in
early regulatory behaviors three times in the neonatal period, at 0.2 weeks (about two days) after birth in the hospital, at 2 weeks of age in the university laboratory and at 4
weeks of age in the participant’s home. Following the work

1. Recruitment was balanced across sites, as the interaction of site by exposure group was not significant for nearly all demographic, maternal, and
perinatal variables. The only exception was that there were more nonsmoking women enrolled at the Illinois site who had private insurance,
χ2(1, N = 304) = 7.97, p < .01. A total of 23 nonexposed–Illinois, 4 nonexposed–Nebraska, 11 tobacco-exposed–Illinois, and 12 tobacco-exposed–
Nebraska participants had private insurance.
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Table 2. Maternal Smoking and Infant Exposure Variables by Tobacco Exposure Group
t test
t

Tobacco-related variable

(df)

Tobacco exposed
M

SD

Nonexposed
M

% (n)

Maternal self-reported prenatal smoking (no. of cigarettes/day)
Trimester 1 			
5.32
5.74
At 16-week interview 			
3.62
6.21
Trimester 2 			
3.84
6.17
At 28-week interview 			
3.80
6.31
Trimester 3 			
3.44
6.18
At 40-week interview 			
3.04
6.07
Cotinine level
16-week maternal urine (ng/ml)
–6.27*** (195)
330.90
536.60		
28-week maternal urine (ng/ml)
–7.71*** (300)
352.89
563.65 		
At delivery maternal urine (ng/ml)
–4.49*** (291)
83.85
198.27 		
At delivery neonate meconium (ng/g)
–2.63*** (249)
192.74
856.51 		
2-week infant urine cotinine (ng/ml)
–1.55
(259)
21.67
32.14 		
4-week infant urine cotinine (ng/ml)
–1.54
(255)
39.80
156.40 		
Exposure cessation group
QUIT 					
49.6 (71/143)
PERSIST 					
50.3 (72/143)

SD

5.64
10.40
12.06
0.39
16.32
19.39

13.78
18.22
19.12
3.43
23.27
23.96

QUIT = quit smoking in Trimester 1 or 2 and remained smoke-free throughout delivery
PERSIST = smoked throughout pregnancy in all three trimesters
* p < .05 ; ** p < .01 ; *** p < .001

of Riese (1982, 1986), research technicians were taught initially in handling and working with neonates and then were
trained in how to administer the NTA items. Before completion of training, each research technician achieved an initial
reliability of greater than 90% with at least 10 neonates (determined by double coding of assessments). Random cases
(10%) were selected for double coding throughout the study
to ensure that ongoing reliability in administration remained
above 90%. The NTA author conducted the extended, initial
training session for study staff at the beginning of the study
and one additional follow-up session during the study. To
maintain blindness to tobacco-exposure group membership,
we designed the study so that examiners who conducted the
interviews with the mothers were different than those who

conducted the NTA assessments with the neonates. However, it was impossible to keep the examiners uninformed of
tobacco use in the home at the 4-week assessment that was
conducted in the home, although tobacco use in the home
is not an indicator of prenatal exposure group membership
per se. Neonates averaged 0.2 weeks of age (SD = 0.14) at the
birth assessment, 2.24 weeks (SD = 0.40) at the 2-week assessment, and 4.22 weeks (SD = 0.47) at the 4-week assessment.
Gestational ages at birth were corrected such that the 2- and
4-week assessments were scheduled to equate conceptional
age. The age range window was ±1 week at the 2-week assessment and ±1.5 weeks for 4-week assessment. There were
no age differences at any assessment between tobacco-exposed and nonexposed groups (all ps > .05).

Table 3. Infant Variables and Physical Growth Parameter Outcomes by Tobacco Exposure Group
t test
Neonate variable

t

Tobacco exposed
(df)

M

SD

Nonexposed
%

M

SD

Length of hospitalization (days)
–0.53
(301)
2.3
1.1 		
2.2
1.2
Gestational age (weeks)
0.67
(302)
39.04
1.20 		
39.13
1.17
5-min Apgar
0.66
(301)
8.78
0.73 		
8.83
0.57
Birth weight (g)
–0.15
(301)
3,428
438 		
3,420
448
Head circumference (cm)
0.70
(299)
34.2
1.5 		
34.3
2.1
Length (cm)
0.16
(299)
50.7
2.2 		
50.7
2.6
Resuscitated with oxygen 					
47 			
Sex (female) 					
49 			
Race/ethnicity
White 					
63 			
African American 					
22 			
Hispanic 					
11 			
Asian 					
1			
Native American 					
1 			
Other 					
1 			
* p < .05 ; ** p < .01 ; *** p < .001.

%

43
50
58
26
12
1
2
1
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Table 4. Intercorrelations of Self-Reported Smoking and Maternal Urine/Infant Meconium Cotinine Value
Variable

1

2

3

4

5

6

7

8

9

10

11

12

1. No. cigarettes per day during first trimester
—
.84** .79** .83** .78** .76** .69** .62** .51** .34** .16*
.04
2. No. cigarettes per day during second trimester 		
—
.96** .89** .96** .93** .65** .66** .59** .36** .27** .03
3. No. cigarettes per day during third trimester 			
—
.87** .94** .96** .68** .65** .60** .34** .29** .03
4. No. cigarettes per day in week prior to 16-week interview 			
—
.84** .83** .65** .91** .63** .48** .34** .19*
5. No. cigarettes per day in week prior to 28-week interview 				
—
.91** .68** .63** .58** .30** .23** .02
6. No. cigarettes per day in week prior to delivery interview 					
—
.58** .60** .62** .32** .36** .03
7. Urine cotinine (ng/ml) at 16-week interview 							
—
.83** .77** .46** .05
.17**
8. Urine cotinine (ng/ml) at 28-week interview 								
—
.59** .30** .12
.00
9. Urine cotinine (ng/ml) at delivery 									
—
.38** .25** .05
10. Infant meconium cotinine level (ng/g) 										
—
.03
.02
11. Infant urine cotinine at 2-week assessment 											
—
.17*
12. Infant urine cotinine at 4-week assessment 												—
* p < .05 ; ** p < .001

The NTA is designed to be conducted from the initiation of
feeding during the interval prior to the next feeding (approximately 3 to 4 hr, depending on feeding schedule), thereby utilizing the neonate’s natural sleep, wake, alertness, and irritability patterns. More details concerning administration procedures
are provided in Riese (1982, 1986, 1987). Briefly, neonatal temperament and behavior in response to feeding, routine handling, auditory and visual stimulation, stressors (a cold disc applied to the neonate’s thigh, aversive stimuli that elicit reflexes),
and interventions (pacifier, examiner talking, swaddling, picking up) are recorded, including the degree of motor activity,
and the level and quality of alertness and orientation. The states
in which to present different stimuli to the neonates are specified in Riese (1987) and were followed accordingly, with the use
of traditional management methods to facilitate acceptable state
for each item and module. Assessments were conducted approximately 45 min after last feeding in a quiet, dimly lit area in
the room. The examiner first recorded the neonate’s length and
weight and rated the neonate’s state on a 6-point scale (1 = quiet
sleep; 2 = active sleep; 3 = drowsy; 4 = alert inactivity; 5 = waking activity; 6 = crying). Next, we administered four modules of the
NTA: attention/ orientation, cold disc stressor, pacifier withdrawal, and soothing maneuvers.
The attention/orientation module was administered when
the neonate was awake and not irritable. During administration, the neonate’s responses to auditory and visual stimuli
and to reflex maneuvers were scored, and summary ratings
of responsiveness and neonate’s reinforcement value were recorded. Auditory stimuli, such as a bell, a rattle, or the examiner’s voice, were presented at the right and left sides of the
neonate three times each for each stimulus, for a total of 18 trials. Each auditory trial was scored on a 4-point scale (1 = no
orienting response; 4 = a strong orienting response with eyes searching and head turning toward the sound). For visual stimuli (e.g.,
bulls-eye, examiner’s face), the stimulus was positioned first
at the center of the visual field, then moved around the neonate’s head to the right or to the left at a 90° angle, back to
the center, around the other side at a 90° angle, and then back
to the center. Each visual item first moved to the right or to
the left twice, for a total of four trials with each item. Visual
items were scored on a 4-point scale (1 = no following response;
4 = sustained fixation and following with eyes and head). Ocular reflexes, optic and acoustic blinks, and rotation were adminis-

tered, as well as elicitation of rooting, sucking, withdrawal to
toothpick prick, and Moro reflexes. Although these items were
scored on a 3- or 4-point scale, such reflex testing typically results in little variability in healthy full-term neonates. Therefore, in response to these maneuvers, the latency to cry was
recorded and the degree of irritability was rated on a 5-point
scale (1 = not irritable; 5 = highly irritable). Finally, the examiner made summary ratings of the neonate’s general appearance and alertness (1 = poor; 5 = excellent), cuddliness (1 = resists and/or thrashes and/or stiffens; 5 = always molds, relaxes and
clings), responsiveness to the different stimuli (1 = not irritable;
5 = highly irritable), consolability (1 = never irritable; 5 = unconsolable), reinforcement value of the neonate to the examiner (1
= glad to be finished; 5 = fun to have at home), and predominant
state throughout the module.
The cold disc stressor module was administered when the
neonate was quiescent and not irritable. This module consisted of five trials in which a metal disc cooled by immersion
in ice water was held against the quiescent neonate’s thigh for
5 s. The neonate’s latency to irritability (in seconds), rated irritability during and after presentation of the stimulus, duration
of soothing if required (in seconds), and total latency to soothe
(in seconds) were recorded. Trials were presented at least 60 s
apart, and the intertrial interval was lengthened if necessary
to soothe the neonate. If the neonate was not soothed after 3
min, subsequent trials were discontinued. An overall summary rating (1 = not irritable to cold disc; 6 = unconsolable) also
was scored at the conclusion of the module.
The pacifier withdrawal module was administered when
the neonate reached a moderate level of irritability, with fussiness and intermittent cry vocalizations. After the examiner
noted the degree of irritability, a pacifier was given to the crying neonate. The latencies to suck and to console (in seconds)
were recorded. After 30 s, the examiner removed the pacifier
while the neonate was still sucking and again recorded the latency to cry, behavioral state, and posttrial irritability level (1
= not irritable, or no soothing needed; 5 = could not console with
pacifier in 3 min). Up to five pacifier withdrawal trials were administered. Trials were terminated if the neonate did not become irritable after 3 min. An overall summary rating (1 = not
irritable, or no soothing needed to pacifier withdrawal; 5 = could not
console with pacifier in 3 min on any trial) was made at the conclusion of the module.
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The soothing maneuvers module also was administered
when the neonate was at a moderate level of irritability. Trials consisted of graded items designed to foster soothing and
were presented in the following order: soothingly talking to the
neonate, soothing talking plus patting the neonate’s stomach,
putting the neonate in the prone position, lifting the neonate to
the shoulder, swaddling the neonate, and cradling the swaddled neonate horizontally. Before each trial, the examiner rated
the degree of irritability, whereas after each trial, the examiner
rated degree of soothability. At the end of the module, the examiner made an overall summary rating (1 = no soothing needed;
5 = not soothed by any technique). When the NTA was concluded,
the examiner scored the neonate’s final behavior state.
Other potential influences on neonatal self-regulation.
Smoking during pregnancy is related to maternal and neonatal risk factors—such as lower maternal education, depression,
psychopathology symptoms (e.g., Baghurst, Tong, Woodward, & McMichael, 1992; Schuetze & Eiden, 2006; Wakschlag,
Pickett, et al., 2002), maternal health, and perinatal complications—which are associated with adverse developmental outcomes independent of exposure (e.g., Eyler & Behnke, 1999;
Schuetze & Eiden, 2007; Schuetze, Eiden, & Dombkowski,
2006). During all study sessions, women completed questionnaires and study instruments, including a brief psychiatric symptom screening (Brief Symptom Inventory; Derogatis,
1975), the Conners Adult ADHD Rating Scale: Short (Conners, Erhardt, & Sparrow, 1998), and the Woodcock–Johnson
Brief Intellectual Ability assessment (Woodcock, McGrew &
Mather, 2001). Standardized scores derived from instrument
normative tables were used in the analyses.

Analysis
Creating factor scores. Unlike in previous studies with the
NTA, we elected to pool and reduce the dependent variables
into meaningful constructs to enhance reliability using princi-
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pal axis factor analysis with oblique (promax) rotation. Those
items (largely the reflex items) with communalities of less than
0.35 were eliminated because of unreliability (Gorsuch, 1983).
As recommended by Gorsuch (1983), we examined eigenvalues (>1), scree plots, and the percentage of variance explained
(>10%) to select the number of factors to retain. Results indicated that a three-factor solution best fit the data. The factor
pattern matrix is shown in Table 5. Factor 1 was labeled Irritable Reactivity, as it was composed largely of the neonate’s irritable reaction to the auditory and visual stimuli and to routine
handling as a part of reflex elicitation and maneuvers. Factor
2, composed of the neonate’s orientation and attention to auditory and visual stimuli, was labeled Attention. Finally, the
items that involved reactions to the cold disc, pacifier, and
soothing maneuvers, as well as behavior prior to the next
feeding, loaded on the third factor, labeled Stressor Dysregulation. The average factor intercorrelations were as follows: for
Irritable Reactivity and Attention, r = –.20; for Irritable Reactivity and Stress Dysregulation, r = .46; and for Attention and
Stress Dysregulation, r = .11. The three computed factor scores
for each participant at each time point were used as the dependent variables, and the means and standard errors of each factor by exposure group are plotted in Figure 1a.
Developing the baseline growth model. To evaluate the
impact of prenatal tobacco exposure on the development of
neonatal regulation, we used hierarchical linear models to
model change across the three time points, with a separate
model for each regulatory factor. Hierarchical linear modeling
takes advantage of the increased reliability of change assessments when data are collected at more than two time points to
characterize developmental processes and deviations. The first
analytic step was to determine the baseline growth model derived from the unconditional model that included only a person-level variance term (i.e., a random intercept). Before any
modifications were made to the structure of either age or the
variance components in the model, gestational age was introduced as a covariate in each model because of its known im-

Table 5. Neonatal Temperament Assessment Factor Structure and Observed Interfactor Correlations
Factor loading
Neonatal temperament assessment item

Irritable reactivity

Attention

Irritability before feeding
Irritability to visual stimuli
Irritability to auditory stimuli
Irritability to handling
Irritability to reflex elicitation
Latency to soothe after Moro reflex
Soothability after reflex elicitation
Mean visual following—bull’s-eye
Mean auditory orienting—rattle
Mean auditory orienting—bell
Mean auditory orienting—voice
Mean visual following—face and voice
Overall alertness summary
Cold disc stressor summary
Pacifier withdrawal summary
Soothing maneuvers summary
Rated reinforcement value

0.40
0.88
0.80
0.89
0.89
0.70
0.85
–0.18
–0.07
–0.04
–0.14
–0.09
–0.19
0.47
0.41
0.41
–0.67

0.06
–0.12
–0.19
–0.11
–0.06
–0.02
–0.11
0.67
0.87
0.87
0.90
0.61
0.87
0.09
0.13
0.07
0.34

Significant factor loadings (above 0.60 or below –0.60) are presented in boldface.

Stress dysregulation
0.81
0.43
0.37
0.44
0.41
0.40
0.40
0.05
0.10
0.10
0.12
0.10
0.08
0.65
0.81
0.89
–0.32
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Figure 1. Growth in attention, irritable reactivity, and stress dysregulation factor scores in neonates. (a) Tobacco-exposed and nonexposed neonates; (b) tobacco-exposed neonates whose mothers quit in the first or second trimester, those who persisted, and nonexposed neonates.

pact on neonatal neurobehavior (e.g., Korner, Brown, Dimiceli, & Forrest, 1989; Riese et al., 1985). Gestational age was a
significant predictor of each of the dependent variables in the
linear growth models of age: for Attention, t(300) _ 3.61, p _
.001; for Irritable Reactivity, t(304) = 2.72, p < .01; and for Stress
Dysregulation, t(304) = 2.26, p < .03. Therefore, we retained
this variable as a covariate in all models. Recruitment site was
included in all models as a covariate to control for any spurious site-specific variance.
Visual inspection of spaghetti plots of individual factor
scores across the three observations suggested that modeling
age as a quadratic process might be most appropriate to describe growth in the Irritable Reactivity and Stress Dysregulation constructs. Although Attention growth appeared linear, fit of the quadratic term was evaluated for consistency.
In these analyses, age was centered at 0.2 weeks, and each
of the three factor scores was then fitted as functions of linear and quadratic (centered) age. The coefficient for the quadratic term did not differ from zero for Attention, t(676) =
–0.17, p > .86, but differed from zero for both Irritable Reactivity, t(675) = –6.49, p < .0001, and Stress Dysregulation,
t(683) = –7.64, p < .0001.
Next, we considered deviations in modeling the personlevel covariance structure, where the coefficient of the age
term was allowed to vary in each of the models. For the linear
model of Attention, model fit comparisons indicated that the
random-intercept-only model was preferred (Akaike information criterion [AIC] of 2,423.1 vs. 2,424.4 for the random inter-

cept-and-slope model; Bayesian information criterion [BIC] of
2,430.5 vs. 2,439.3 for the random intercept-and-slope model).
For Irritable Reactivity, the model allowing for both random
intercept and slope terms improved model fit when both
AIC values (2,404.8 vs. 2,435.2 for the random-intercept-only
model) and BIC values (2,412.2 vs. 2,442.6) were considered.
A fairly wide range of quadratic trends were also exhibited
in the individual plots for Irritable Reactivity. Thus, models
were fitted where the (centered) age and quadratic age terms
were allowed to vary across neonates in separate models. Like
Stress Dysregulation, the growth model that included random
intercept and slope terms significantly improved model fit
over the random-intercept-only model when AIC values alone
were considered (2,260.7 vs. 2,267.7 for the random intercept
only) but not when considering BIC (2,275.6 vs. 2,275.2). The
final baseline model for Attention, then, was linear in age,
with only the intercept as a random coefficient, whereas for
Irritable Reactivity and Stress Dysregulation, linear and quadratic changes in age were modeled, with only the intercepts
allowed to vary randomly among neonates.
Modeling the impact of exposure. Exposure-related predictors were considered in separate models and included
exposure group (tobacco exposed vs. nonexposed); exposure-cessation group: QUIT (stopped smoking during pregnancy during the first or second trimester and remained quit
throughout the third trimester) versus PERSIST (smoked
throughout pregnancy); average self-reported smoking for
each trimester (cigarettes/day); average self-reported smoking
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Table 6. Exposure-Related Predictors and Impact on the Neonatal Physical Growth Measured at Birth
Physical growth measured at birth
Birth weight

Body length

b

SE

β

b

SE

β

b

SE

–2.49
–6.70
–10.41†
–11.56*
–11.55*
–14.55*

5.37
6.77
5.46
5.47
5.54
5.69

–0.03
–0.07
–0.11†
–0.12*
–0.12*
–0.15*

–0.01
–0.01
–0.03
–0.03
–0.03
–0.04†

0.02
0.03
0.02
0.02
0.02
0.02

–0.03
–0.02
–0.06
–0.06
–0.07
–0.98†

–0.02
–0.05
–0.04
–0.05
–0.05
–0.05

0.03
0.04
0.03
0.03
0.03
0.03

–0.05
–0.10
–0.08
–0.09
–0.10
–0.09

–0.04
–0.03
–0.07
–0.01

0.04
0.03
0.08
0.02

–0.09
–0.07
–0.05
–0.02

–0.09*
–0.01†
–0.30**
0.02

0.04
0.03
0.10
0.03

–0.15*
–0.10†
–0.18**
0.04

Exposure predictor
Maternal self-reported average smoking (no. of cigarettes/day)
Trimester 1
16-week interview
Trimester 2
28-week interview
Trimester 3
40-week interview
Cotinine level (100 ng/ml, ng/g)
16-week maternal urine ****
28-week maternal urine ****
At delivery maternal urine ****
At delivery infant meconium **

Head circumference

–17.24* 7.85 –0.16*
–9.88
6.06 –0.09
–46.78 18.32 –0.15*
–0.05
4.91 <–0.01

β

b = unstandardized beta weight; SE = standard error; β = standardized beta weight.
† p < .10 ; * p < .05 ; ** p < .01

at the 16-, 28-, and 40-week interviews (cigarettes/day); maternal urinary cotinine level at the 16-, 28-, or 40-week interviews (scaled in units of 100 ng/mL); and neonate meconium
cotinine level (scaled in units of 100 ng/g). To characterize the
impact of exposure on physical growth, we conducted t tests
where the exposure variable was categorical and regressions
were used for continuously distributed exposure variables.
For the hierarchical growth models, we developed conditional
models to test the hypotheses including the effect of the exposure-related predictor on both the intercept and growth parameters. We conducted the analyses, centering at 0.2, 2, and
4 weeks, respectively, in order to characterize the relation to
neonatal behavior at each time point. We entered each exposure-independent variable as a predictor of the pattern of
growth (intercept, linear change, quadratic acceleration) and
then used a backwards trimming procedure to select the best
fitting conditional model, deleting those when not significant
for the higher growth term and then working progressively
backwards through the growth terms. We scaled the continuous predictors so that the estimated parameter represented the
incremental change in the dependent variable that was associated with each additional cigarette smoked or each additional
100 cotinine units at that interview.
Selection of covariates. We considered a range of covariates for inclusion: marital status, maternal education, family
income, mother’s age at delivery, average number of alcoholic
drinks per day during the first trimester, Medicaid status, neonate sex, neonate and mother’s race/ethnicity (White vs.
non-White), neonate environmental tobacco exposure (as
measured by cotinine in neonate urine collected at the 2- and
the 4-week assessments), maternal prescription medication
use (antidepressant, pain, or asthma medication, each coded
as 0 = absent; 1 = present), gravida, parity, weight gain, mother
health and delivery variables (diabetes, heart disease, placental abruption, thyroid, anemia, hypertension/pre-eclampsia,
infection, delivery type [vaginal vs. cesarean/other] with the
same 0,1 coding), Brief Symptom Inventory summary index,
Attention Deficit/Hyperactivity Disorder index of the Conners Adult ADHD Rating Scale: Short, and the Woodcock–

Johnson Brief Intellectual Ability assessment overall IQ estimate. Covariates were analyzed separately and selected
according to the methods of J. L. Jacobson and Jacobson (1996)
to control the influence of variables that co-occur with prenatal smoking without inappropriately reducing exposure-related variance. If the correlation of the covariate with both exposure status (nonexposed vs. tobacco exposed) and the NTA
factor score differed from zero at the p < .10 level, the covariate was included in the models.
For Attention, mother’s age at delivery, maternal education, and the maternal IQ estimate were retained for consideration as covariates through these methods. All three candidate covariates were added to the baseline model, and a
backwards stepwise procedure was used to determine which
among them was to be retained in the final model. Mother’s
age was removed first from the model, t(292) = 0.12, p > .90,
followed by education, t(291) = 0.58, p > .55. The remaining covariate—mothers’ IQ estimate—t(291) = 3.33, p = .001, was retained. None of the aforementioned covariates met the criteria for model inclusion for either Irritable Reactivity or Stress
Dysregulation.

Results
Physical growth indices at birth as a function of exposure
group status are shown in Table 3. Tobacco-exposed and nonexposed groups did not differ in birth weight, t(301) _ _0.15,
p _ .88; head circumference, t(299) = 0.70, p > .48; or length,
t(299) = 0.16, p > .87. Within the exposed neonates, there
were no differences in these physical growth indices in those
born to women who quit during the first or second trimester
(QUIT) and those whose smoking persisted throughout pregnancy (PERSIST; all ps > .47). Table 6 contains the results of regression models with the self-reported smoking and biospecimen predictors. Despite the lack of overall exposure group
differences in birth weight, a dose– response relation was evident. Each additional cigarette smoked in the third trimester
as reported by the mother was associated with an 11.55-g decrement in birth weight. A similar trend was observed for the
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number of cigarettes reported for the second trimester. The average number of cigarettes smoked per day in the week prior
to both the 28- and 40-week interviews was associated with a
respective birth weight decrement of 11.56 and 14.55 g, respectively. Furthermore, cotinine in maternal urine at both the 16and 40- week interviews predicted birth weight, with a respective difference of –17.24 and –46.78 per 100 ng/ml cotinine.
For body length, a similar dose–response pattern was evident,
where the maternal urine cotinine levels at 16 and 40 weeks
predicted decrements in body length at birth. Marginal trends
were observed for the maternal urinary cotinine values at the
16-, 28-, and 40-week interviews. The magnitude of these effects was similar. Neither self-reported smoking nor biospecimen results predicted head circumference.
The estimated intercept and linear growth (if applicable)
parameter values associated with the exposure predictors
for the hierarchical growth models for the Irritable Reactivity, Attention, and Stress Dysregulation factor scores are presented in Table 7. Tobacco-exposed and nonexposed neonates
differed in Attention factor score obtained shortly after birth
and in the rate of growth. The pattern of Attention growth is
shown in Figure 1a. Tobacco-exposed neonates had, on average, lower Attention scores by 0.32 at two days after birth than
did nonexposed neonates, t(765) = –3.23, p < 0.01. The significantly higher rate of growth (γ = 0.10) evidenced among tobacco-exposed neonates, t(609) = 2.88, p < .01, resulted in a diminishing difference in Attention score means between the
two groups at the 2-week time point of 0.14, t(299) = –2.01, p
< .05, and comparable Attention scores between the groups at
the 4-week assessment, t(692) = 0.60, p > .55.
Among tobacco-exposed neonates, the PERSIST and QUIT
groups demonstrated different Attention factor scores shortly
after birth and different rates of growth of these scores. The
PERSIST group had, on average, lower Attention scores by
0.40 at two days after birth as compared with nonexposed neonates, t(762) = –3.266, p < 0.01, and the difference of 0.24 between the QUIT and nonexposed groups was also significant,
t(766) = –1.98, p < .05. The significantly higher rate of growth
(γ = 0.126) evidenced among PERSIST neonates, t(605) = 2.94,
p < .01, resulted in a diminishing difference in Attention score
means of 0.175 between the PERSIST and nonexposed groups
at age 2 weeks, t(298) = –1.98, p < .05, and comparable Attention scores between the groups at the 4-week evaluation, t(699)
= 0.67, p > .50. The QUIT group demonstrated a higher, but
nonsignificant, rate of growth (γ = 0.072), t(609) = 1.71, p > .08
compared with the nonexposed group. Growth trajectories are
shown in Figure 1b.
Self-reported average number of cigarettes smoked per
day during the first trimester was related to the pattern of
Attention growth in a dose-dependent fashion, with each cigarette smoked associated with a 0.034-reduction in Attention
score at 0.2 weeks, t(775) = –3.22, p < .01, and with a faster
rate of change of 0.012 in Attention score, t(606) = 3.15, p <
.01, across the neonatal period. A similar pattern was observed for self-reported smoking during the second trimester and the average number of cigarettes smoked per day reported in the week prior to the 28-week interview, with each
cigarette smoked associated with a 0.047 and a 0.042 reduction, respectively, in Attention score at 0.2 weeks, t(779) =
–4.03, p < .0001, t(784) = –3.72, p < .001, and with a faster rate
of Attention score change of 0.014 and 0.011, t(607) = 3.36, p <
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.0001, t(602) = 2.69, p < .006, across the neonatal period. Average self-reported smoking during the third trimester and in
the week prior to the 40-week interview also was related negatively to the Attention factor score, where each reported cigarette smoked per day was related to a 0.045 and 0.044 Attention score reduction, respectively, at 0.2 weeks, t(782) =
–3.74, p < .001, and t(771) = –3.43, p < .001, and was also associated with a 0.012 and 0.011 higher rate of change in Attention score, t(608) = 2.94, p < .01; t(600) = 2.45, p < .02. Cotinine
levels in maternal urine collected at 28 weeks and at delivery
were related to the pattern of growth in Attention scores such
that greater assayed cotinine levels were associated with a reduction in Attention scores of 0.023 and 0.087 at 0.2 weeks,
respectively, t(771) = –2.00, p < .05, t(737) = –2.35, p < .02, and
with a marginally faster rate of change of 0.021 in Attention
scores (γ = 0.021), t(579) = 1.69, p < .10. At 2 weeks of age,
neonatal Attention scores were related negatively to average
self-reported smoking during the second, t(305) = –2.74, p <
.01, and third, t(306) = –2.71, p < .01, trimesters and smoking in the week prior to the 28-week, t(305) = –2.93, p < .01,
and 40-week, t(304) = –2.71, p < .01, interviews and was associated marginally with self-reported smoking in the first trimester, t(307) = –1.78, p < .10, and with maternal urine cotinine level at delivery, t(291) = –1.89, p < .10. All self-reported
smoking and cotinine levels were not related to Attention
score level at neonates’ 4 weeks of age ( ps > .30).
The group-related pattern of Irritable Reactivity growth
is shown in Figure 1a. Unlike Attention, growth patterns did
not differ significantly by exposure group classification at 0.2
weeks, t(831) = 0.36, p > .72, or 2 weeks, t(752) = 1.52, p >
.12. The tobacco-exposed group was consistently more irritable (difference in intercepts between tobacco-exposed and
nonexposed groups of 0.039) across the neonatal period and
reached marginal significance at 4 weeks of age (γ = 0.158),
t(684) = 1.67, p < .10. Similarly, no differences were noted between the nonexposed group and either of the exposure cessation groups: QUIT, t(827) = 0.86, p > .39, or PERSIST, t(832)
= –0.33, p > .74, at 0.2 weeks, respectively. There were marginally significant Irritable Reactivity score differences between PERSIST and nonexposed participants at 2 weeks (γ
= 0.214), t(769) = 1.67, p < .10. Average self-reported smoking in each trimester or at each interview was not related to
any Irritable Reactivity growth parameters, nor were maternal urine or meconium cotinine levels related to this factor at
any time point.
Like Irritable Reactivity, Stress Dysregulation scores did
not differ by exposure group classification, t(841) = –0.26, p >
.79, nor were there any differences between the nonexposed
group and either the QUIT or the PERSIST group, t(836) =
–0.61, p > .54, and t(841) = 0.13, p > .89, respectively. For Stress
Dysregulation, the variables of self-reported smoking at each
interview, cotinine levels in maternal urine, and cotinine levels in neonatal meconium were unrelated to growth in Stress
Dysregulation scores or to Stress Dysregulation scores at 0.2,
2, or 4 weeks of age. Self-reported smoking during the first
trimester was related marginally to quadratic growth (γ =
–0.005), t(665) = –1.79, p < .08, but not to Stress Dysregulation
scores at any age, and average self-reported smoking in second and third trimesters was not related to any Stress Dysregulation growth parameters over the course of neonates’ first
month of life.
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Table 7. Exposure-Related Predictors and Impact on Neonatal Self-Regulation, Attention/Orientation, Irritable Reactivity, and
Stressor Dysregulation Growth Parameters
0.2 Weeks
Variable

Quadratic

2 Weeks

SE

Intercept

0.098** –0.318**

0.010

–0.141*

0.126** –0.402**
0.072† –0.240*

0.123
0.121

0.012**
0.005
0.014***
0.011**
0.012**
0.011*
0.004
0.007
0.021†
0.003

Slope

Intercept

SE

4 Weeks
Intercept

SE

0.070

0.055

0.092

–0.175*
–0.110

0.088
0.086

0.078
0.034

0.116
0.113

0.011
0.014
0.012
0.011
0.012
0.013
0.015
0.012
0.036
0.009

–0.014†
–0.002
–0.023**
–0.023**
–0.023**
–0.025**
–0.009
–0.011
–0.050†
–0.010

0.008
0.010
0.008
0.008
0.008
0.009
0.011
0.008
0.026
0.007

0.010
0.008
0.004
–0.002
0.001
–0.003
–0.001
0.002
–0.009
–0.004

0.010
0.014
0.011
0.010
0.011
0.012
0.014
0.011
0.033
0.008

Attention/orientation
Tobacco-exposed/nonexposed group status 		
Exposure-cessation group
PERSIST 		
QUIT 		
Maternal self-reported average smoking (no. cigarettes/day)
Trimester 1 		
16-week interview 		
Trimester 2 		
28-week interview 		
Trimester 3 		
40-week interview 		
16-week maternal urine 		
28-week maternal urine 		
At delivery maternal urine 		
At delivery infant meconium 		

–0.034**
–0.012
–0.047***
–0.042***
–0.045***
–0.044***
–0.015
–0.023*
–0.087*
–0.016†

Irritable reactivity
Tobacco-exposed/nonexposed group status
–0.016
Exposure-cessation group
PERSIST
–0.047
QUIT
0.008
Maternal self-reported average smoking (no. of cigarettes/day)
Trimester 1
–0.003
16-week interview
0.003
Trimester 2
–0.003
28-week interview
–0.001
Trimester 3
–0.002
40-week interview
–0.002
Cotinine level (100 ng/ml, ng/g)
16-week maternal urine
–0.002
28-week maternal urine
–0.005
At delivery maternal urine
–0.005
At delivery infant meconium
–0.002

0.094

0.039

0.107

0.155

0.102

0.158†

0.094

0.229
–0.018

–0.045
0.113

0.135
0.132

0.214†
0.106

0.128
0.126

0.143
0.158

0.119
0.116

0.016
–0.004
0.012
0.009
0.008
0.009

0.000
–0.011
0.000
–0.001
0.003
0.003

0.012
0.015
0.012
0.012
0.012
0.013

0.017
–0.009
0.013
0.011
0.012
0.014

0.011
0.014
0.011
0.011
0.011
0.011

0.009
0.013
0.007
0.015
0.010
0.011

0.010
0.014
0.010
0.010
0.011
0.011

0.021
0.023
0.030
0.006

–0.018
–0.011
–0.012
0.016

0.017
0.013
0.039
0.011

0.014
0.015
0.026
0.021

0.016
0.012
0.038
0.010

0.037
0.009
0.032
0.010

0.015
0.012
0.034
0.009

Stressor dysregulation
Exposure-cessation group
PERSIST
–0.050
QUIT
–0.021
Maternal self-reported average smoking (no. of cigarettes/day)
Trimester 1
–0.005†
16-week interview
0.003
Trimester 2
–0.004
28-week interview
–0.003
Trimester 3
–0.003
40-week interview
–0.003
Cotinine level (100 ng/ml, ng/g)
16-week maternal urine
–0.003
28-week maternal urine
–0.007
At delivery maternal urine
–0.004
At delivery infant meconium
–0.001

0.144
0.113

0.016
–0.073

0.123
0.121

0.112
0.062

0.117
0.115

–0.162
0.052

0.109
0.106

0.017
–0.016
0.011
0.007
0.007
0.010

–0.003
0.007
–0.002
0.004
0.001
–0.000

0.011
0.014
0.011
0.011
0.011
0.012

0.012
–0.014
0.006
0.006
0.006
0.007

0.010
0.013
0.010
0.010
0.010
0.010

–0.008
–0.016
–0.014
0.013
–0.008
–0.008

0.009
0.013
0.010
0.012
0.010
0.010

0.009
0.026
–0.003
0.003

0.017
–0.007
0.038
0.005

0.015
0.012
0.036
0.010

0.022
0.018
0.020
0.005

0.015
0.011
0.034
0.009

0.004
–0.004
–0.027
–0.005

0.014
0.011
0.031
0.008

Covariates for the attention/orientation model are gestational age, site, and the estimated maternal overall intelligence score, and covariates for the
irritable reactivity and stressor dysregulation models are gestational age and site. QUIT = quit smoking in Trimester 1 or 2 and remained smokefree throughout delivery; PERSIST = smoked throughout pregnancy in all three trimesters.
† p < .10 ; * p < .05 ; ** p < .01 ; *** p < .001
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Discussion
The impact of prenatal tobacco exposure on the early development of emergent self-regulatory processes and on physical growth at birth was assessed with a prospective design,
indexing exposure through self-report and bioassays collected
at several time points during pregnancy. Neonatal self-regulatory behaviors for modulating attention, irritability, and
response to stressors were assessed three times in the first
month of life and empirically parsed into meaningful constructs, enabling characterization of the dynamic impact of
prenatal tobacco exposure on the trajectories of change in light
of substantial growth and instability in this very early period
(Korner, Kraemer, Reade, Forrest, & Dimiceli, 1987). This finegrained analytic strategy enabled a number of new insights
into the effects of exposure on the very early development of
self-regulatory behaviors in several domains.
Although the prevalence, amount, and persistence of smoking in pregnant women today differs from that in previous decades, the oft-reported continuous dose–response relation between pregnancy smoking and birth weight was evident here.
Heavier and more persistent smoking across pregnancy impacted birth weight and body length deleteriously. Self-reported second- and third-trimester smoking, self-reported
smoking at the 28- and 40-week interviews, and cotinine in
maternal urine at 16 and 40 weeks, predicted birth-weight decrements. The magnitude of the exposure effect on birth-weight
effect was largest for these third-trimester smoking predictors
compared with those measured earlier in pregnancy. Maternal
urinary cotinine at delivery also was associated with significant body length decrements. Marginal trends were observed
for maternal urine cotinine levels at the 16-, 28-, and 40-week
interviews. In contrast to these dose–response relations, the
lack of exposure group differences in these indices of physical growth at birth is likely a consequence of lower amount of
tobacco exposure overall compared with cohorts ascertained
in the 1970s and 1980s, the sample selection methods to minimize other influences and exposures, and the greater sensitivity of continuous measures of exposure in comparison with
gross grouping. Neither exposure-group-level nor dose–response differences in head circumference were evident, suggesting that the protective, brain-growth-sparing mechanism
was not affected by prenatal tobacco exposure, unlike what
has been observed in prenatally cocaine exposed neonates (Eyler, Behnke, Conlon, Woods, & Wobie, 1998).
Importantly, the pattern of development of attention skills
differed among tobacco-exposed and nonexposed neonates
across the first month of life. Consistent with the stated hypotheses, tobacco-exposed neonates showed less orientation and attentive tracking behaviors to auditory and visual stimuli. Interestingly, exposure group differences were
not constant over the first month of life. Differences were
most evident on the Attention factor scores from the assessment conducted shortly after birth and remained apparent at
2 weeks of age. By 4 weeks of age, however, Attention scores
were comparable between the two groups, contrary to prediction. This average trajectory is consistent with a general pattern of developmental catch-up, where the initial reduced
level of performance in tobacco-exposed neonates was accompanied by a more rapid rate of development, resulting in comparable skills at the end of the observation period. Furthermore, attention skills scores were lower shortly after birth in
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tobacco-exposed neonates whose mothers smoked more and
more persistently across pregnancy compared with those who
quit smoking during or before the second trimester. Of note
too is the relatively modest change in Attention skills in nonexposed neonates relative to the fairly steep rate of change for
tobacco-exposed neonates, which again was greater in those
who smoked more and more persistently in pregnancy.
Clearly, early in the neonatal period, attention skills differed in tobacco-exposed neonates relative to their nonexposed peers. What is unclear is whether this difference reflects
an effect of withdrawal or is a unique exposure-related developmental vulnerability in this period of rapid change. The differences in attention observed shortly after birth are consistent with withdrawal effects, reflecting the residual rebound
impact of cessation of nicotine exposure that occurs as a consequence of birth. This interpretation is consistent with earlier
findings where exposure also was measured with self-report
(e.g., Fried et al., 1987; S. W. Jacobson, 1984; G. A. Richardson
et al., 1989; Saxton, 1978; Streissguth, Sampson, Barr, Bookstein, & Carmichael, 1994). These findings are also consistent with those from a more recent study that included bioassays of exposure and was specifically designed to examine
withdrawal in the first days of life (Godding et al., 2004). The
dose–response relation observed in the present between selfreported maternal smoking in the third trimester and at the
delivery interview, as well as cotinine levels in maternal urine
at delivery and in neonatal meconium, and the level of attention behavior observed shortly after birth support the withdrawal interpretation.
Withdrawal effects from progressive nicotine clearing also
might contribute to the substantive differences observed in Attention scores that persisted at 2 weeks of age. The difference
in Attention scores between tobacco-exposed and nonexposed
neonates was substantially smaller (about half in magnitude)
at 2 weeks of age compared with shortly after birth. Self-reported smoking in the third trimester and at the 40-week interview, as well as cotinine levels in maternal urine at delivery,
predicted the differences of Attention scores between tobaccoexposed and nonexposed infants at 2 weeks of age. However,
cotinine levels in neonatal meconium were not related to attention behaviors at 2 weeks of age, which would have been
expected if the exposure group differences were due to receding withdrawal effects.
Typically, 2 weeks of age is considered beyond the window when acute withdrawal effects are observed (Stroud, Paster, Papandonatos, et al., 2009). Unlike Godding et al. (2004),
women in the present sample reported smoking substantially
fewer cigarettes per day. The decreased number of cigarettes
per day across pregnancy results in a much lower dose of nicotine to be cleared after birth and thereby might decrease the
likelihood and severity of withdrawal effects shortly after
birth and certainly 2 weeks later. In the present study, neonates whose mothers quit smoking during pregnancy showed
poorer attention and orientation skills shortly after birth compared with those who were nonexposed, which also is not
consistent with withdrawal effects. Furthermore, the amount
of smoking reported in the first and second trimesters, as well
as in the week prior to the 28-week interview, predicted attention skills at 2 weeks of age, earlier in pregnancy than would
be a consequence of nicotine clearing. However, the general
consistency is that smoking across pregnancy, and the resultant substantive correlations between smoking indicators mea-
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sured at different points during pregnancy, makes it difficult
to attribute independent effects on neurobehavior at each age.
The observed differences in attention early in the neonatal period, however, also are not likely to be due to secondhand tobacco exposure, as secondhand smoke exposure was low in
the neonatal period, confirmed by the low cotinine levels in
neonate urine and the much smaller relation to prenatal smoking amounts of our present study.
Although exposure-group-related differences in attention
were expected at 4 weeks of age, the average trajectories did
not differ between exposure groups at the end of the neonatal period. Neither self-reported smoking nor cotinine levels
measured in biospecimens were related to exposure group differences in Attention scores at 4 weeks of age, consistent with
results obtained by Yolton et al. (2009). The pattern of skill
growth for tobacco-exposed neonates was consistent with initial deficits followed by subsequent “recovery,” where at 4
weeks of age, all neonates showed comparable attention skills.
In this period of rapid developmental growth in attention
skills for all neonates, tobacco-exposed neonates show early
deficits, as well as faster growth rates, both of which were related to the degree of exposure. The longitudinal design used
here disentangled the age-specific exposure effects in the context of the developmental trajectory of skill development.
Also contrary to hypothesis, exposure-group-level (tobacco exposed vs. nonexposed) differences in the Irritable Reactivity factor scores shortly after birth were not significant;
nor were there exposure group effects on linear or quadratic
growth rates. These findings contrast with those from other
studies that used both self-report (Fried & Makin, 1987; S. W.
Jacobson, 1984; Nugent, Lester, Greene, & Wieczorek-Deering,
1996; Picone et al., 1982; Schuetze & Eiden, 2007) and bioassays (Godding et al., 2004; Law et al., 2003; Mansi et al., 2007;
Stroud, Paster, Goodwin, et al., 2009) to index prenatal tobacco
exposure. What is of interest here is the impact on the developmental pattern, where the consistent exposure-related differences in Irritable Reactivity scores between groups were visually evident at each age and persistent across the neonatal
period. The magnitude of the estimated difference in irritable reactivity between tobacco-exposed and nonexposed neonates was progressively greater across time points, where at 4
weeks, exposure groups differed marginally. A second look at
the individual trajectories of Irritable Reactivity scores across
age suggested a high degree of between-subjects variability in
exposure-related impacts on Irritable Reactivity scores that is
superimposed upon a general neonatal increase in irritable reactivity across the neonatal period. Person-centered methods
(e.g., Espy, Fang, Charak, Minich & Taylor, 2009) might be applied fruitfully to identify specific groups of neonates with
discrepant neonatal developmental patterns related to exposure. Birth is a stressful, energy-demanding event from which
newborns recover through initial high levels of sleep and low
irritability (Korner, 1996; Korner, Brown, Reade, & Stevenson,
1988). Because the Irritable Reactivity factor is composed of
items that score irritable reactivity to daily living activities—
to handling, physical maneuvers, auditory and visual stimulation—exposure-related irritability would be expected to be
observed routinely and persistently, at least for a subset who
are most vulnerable. Given the importance of irritability to solicit caregiving, these early, subtle differences perhaps set the
stage for the ensuing deviations in maternal–infant behavior
that have been observed (Schuetze & Eiden, 2006, 2007) and
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may be an early precursor to later deviations in emotional dysregulatory behavior (Brook et al., 2000; Wakschlag, Leventhal,
Pine, Pickett, & Carter, 2006).
Although the self-reported average first-trimester smoking
was related marginally to a decrease in the rate of deceleration
in Stressor Dysregulation factor scores, none of the other exposure variables—self-report or biospecimen data—predicted
differences in the rates of change in, or in the age-specific level
of, the dysregulation response to midlevel stressors. Dysregulation behaviors in response to a relatively acute, substantial stressor might be more resilient to the deleterious impact
of prenatal tobacco exposure, given their deeply rooted, evolution-selected, adaptive role in signaling immediate discomfort
and distress. It is important to note, however, that the Irritable Reactivity and Stress Dysregulation factor scores were related substantively and, thus, teasing apart the isolated impact
of exposure on these two dimensions is not a simple endeavor.
Because tobacco-exposed neonates showed more irritability
in response to routine handling as shown by the Irritable Reactivity factor score difference, the introduction of a stressful
stimulus (e.g., cold disc) might not have provoked as much of
an increase in negative emotionality as a result of natural constraints in the neonatal behavioral repertoire, somewhat akin
to a ceiling effect. Including stress biomarkers, such as cortisol
or heart-rate measurements, might reveal latent physiologic
differences that could help disentangle these two dimensions,
as these methods have been successful in revealed exposurerelated differences (e.g., Franco, Chabanski, Szilwowski, Dramaix, & Kahn, 2000; Schuetze & Eiden, 2006).
Sampling methods of this study deserve particular comment, particularly in light of the decadal changes in smoking
behavior, as a contributor to the obtained pattern of findings.
First, women were recruited prospectively in the first trimester, and thus it was impossible to balance selection on persistence of smoking throughout pregnancy. Second, our goal was
to minimize extraneous influences other than smoking; thus,
nonsmoking women were selected specifically to be more
comparable demographically to those who smoked, which certainly resulted in exposure groups that were more similar (although not completely so) than is typically found in community-based samples. Consistent with minimizing extraneous
influences and with our interests in the neurobiologic effects
of nicotine on the nervous system, our goal was to minimize
the impact of other exposures, and thus women who reported
illegal drug use at screening or at interview or who tested positive in biospecimens, as well as those with known heavy alcohol use, were not included in the report here. The benefit of
this sampling design is its highlighting of the prenatal tobacco
exposure effects among the background of risks. The downside, however, is that there were fewer heavier and more persistent smokers in the present study, as higher alcohol and
other drug use is substantially more common in women who
smoke heavily during pregnancy. These sampling differences
must be evaluated carefully in interpreting the pattern of findings across studies.
One strength of this effort is the longitudinal design that
permitted characterization of the impact of prenatal tobacco
exposure on the development of regulatory skills across the
first month of life. These findings serve to link those from
other cross-sectional studies that have focused on withdrawal
effects, regulatory behavior shortly after birth, and the longerterm, residual impacts of later exposure at the end of neonatal
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period. The longitudinal measurement and growth modeling
strategy takes advantage of the increased reliability of change
to describe developmental processes and deviations (Rogosa
& Willett, 1985). The average trajectory was consistent with a
catch-up pattern for attention skills, consistent with self-righting resilience in development, at least in this sample with relatively low amounts of smoking and less confounding by
other exposures. The observed trajectory, however, is simply a
mathematical average, and is superimposed on substantial individual variation. Of course, the effects observed here in the
neonatal period are only the first step in establishing the dynamic impact of prenatal tobacco exposure on the developing
nervous system that supports regulatory processes within the
broader context of parenting and the social environment that
also interactively shapes development as it unfolds. Whether
the initial developmental patterns observed in the neonatal
period are related to disturbances in later attention and emotion regulation behaviors is an important future question,
as these more basic neonatal skills are integrated into the increasingly complex behavior repertoire of the developing infant and child that are expressed dynamically in varying social contexts.
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